Efficacy Of Hiatal Closure For GERD

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT06280664
Status
Recruiting
Apply to this trial

Conditions

  • Gastro Esophageal Reflux

Eligibility Criteria

Sex
ALL
Age
18 Years - 50 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

Key Dates

Start date
Oct 2, 2020
Status verified
Jan 2026
Primary completion
Oct 31, 2028
Completion
Oct 31, 2028

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Concentration of pH testing [ Time Frame: at 1 and 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of ChicagoChicagoIllinois60637
Carlisa Dixon
[email protected]
773-834-4337
Leila Yazdanbakhsh
[email protected]
773-834-5087

Find similar trials in Chicago, IL

By research site
The University of Chicago· Chicago, IL

Related Studies